Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer

Urological Research

Volumn 25, Issue 1, 1997, Pages 1-7

  Liukkonen, T J O ^a   Lipponen, P K ^b   Helle, M ^a   Jauhiainen, K E ^a   Ala Opas, M ^c   Tuhkanen, K ^c   Forsell, T ^d   Granbacka, P ^e   Hynninen, O ^f   Jauhiainen, K ^a   Liukkonen, T ^a   Juusela, H ^g   Kemppainen, P ^h   Korhonen, H ⁱ   Lahdes Vasama, T ^j   Rannikko, S ^j   Ruutu, M ^j   Lehtoranta, K ^k   Talja, M ^k   Hakkinen J ^l   Hallstrom P ^l   Kontturi, M ^l   Lukkarinen, O ^l   Raitanen, M ^l   Nurmi, M ^m   Rajala, P ^m   Ottelin, J ⁿ   Pellinen, P ^o   Permi, J ^p   Puolakka, V M ^p   Rintala, E ^j   Tammela, T L ^q   Tainio, H ^q   Usenius, R ^r   more..

^a MIKKELI CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d KYMENLAAKSO CENTRAL HOSPITAL   (Finland)

^e Pietarsaari District Hospital

^f Lahti City Hospital   (Finland)

^g District Hospital of Jorvi   (Finland)

^h KAINUU CENTRAL HOSPITAL   (Finland)

ⁱ SATAKUNTA CENTRAL HOSPITAL   (Finland)

^j HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^k PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^l OULU UNIVERSITY HOSPITAL   (Finland)

^m TURKU UNIVERSITY HOSPITAL   (Finland)

ⁿ Kemi Central Hospital   (Finland)

^o Kokkola Central Hospital   (Finland)

^p Lappeenranta Central Hospital   (Finland)

^q TAMPERE UNIVERSITY HOSPITAL   (Finland)

^r JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

more..

Author keywords

bcl 2; EGFr; MIB 1; p53; superficial bladder cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR; PROTEIN BCL 2; PROTEIN P53;

ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER STAGING; CELL PROLIFERATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SUPERFICIAL CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 8244260094     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00941899     Document Type: Article

References (46)

1. Allan DJ, Howell A, Roberts SA, Williams GT, Watson RJ, Coyne JD, Clarke RB, Laidlaw IJ, Potten CS (1992) Reduction of apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast. J Pathol 167:25
2. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912
3. Barbareschi M, Iuzzolino P, Pennella A, Allegranza A, Arrigoni G, Dalla-Palma P, Doglioni C (1992) p53 protein expression in central nervous system neoplasms. J Clin Pathol 45:583
4. Brown DC, Gatter KC (1990) Monoclonal antibody Ki-67:its use in histopathology. Histopathology 17:489
5. Cattoretti G, Becker MHG, Key G. Duchrow M, Schlüter C, Galle J. Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357
6. Cohen S (1983) The epidermal growth factor. Cancer 51:1787
7. Desoize B (1994) Anticancer drug resistance and inhibition of apoptosis Anticancer Res 14:2291
8. Esrig D, Spruck CH, Nichols PW, Chaiwun B, Steven K, Groshen S, Chen S-C, Skinner DG, Jones PA. Cote RJ (1993) p53 nuclear protein accumulation correlates with mutations in the p53 gene. tumor erade and stage in bladder cancer. Am J Pathol 143:1389
9. Esrig D, Elmajian D, Groshen S, Freeman JA, Stein JP, Chen S-C, Nichols PW, Skinner DG, Jones PA, Cote RJ (1994) Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 331:1259
10. Gerdes J (1990) Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. In: Osborn M (ed) Cancer biology. vol 1. Saunders Scientific Publications, London p 99
11. Haldar S, Negrini M, Monne M, Sabbioni S, Croce CM (1994) Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 54:2095
12. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann D, Hawkins IR and National Bladder Cancer Collaborative Group A (1983) Superficial bladder cancer: Progression and recurrence. J Urol 130:1083
13. Isaacs WB, Carter BS, Ewing CM (1991) Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res 51:4716
14. Isola J, Visakorpi T, Holli K, Kallioniemi OP (1992) Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Natl Cancer Inst 84:1109
15. Joensuu H, Pylkkanen L, Toikkanen S (1994) Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 145:1191
16. Key G, Backer MHG, Duchrow M, Schlüter C, Gerdes J (1992) New Ki-67 equivalent murine monoclonal antibodies (MIB-1-3) prepared aaainst recombinant parts of the Ki-67 antigen. Anal Cell Pathol 4:181
17. Kiemeney LALM, Witjes JA, Verbeek ALM, Heijbroek RP, Debruyne FMJ and members of the Dutch South-East Cooperative Urological Group (1993) The clinical epidemiology of superficial bladder cancer. Br J Cancer 67:806
18. Leonardi E, Girlando S, Serio G, Mauri FA, Perrone G, Scampini S, Dalla-Palma P, Barbareschi M (1992) PCNA and Ki-67 expression in breast carcinoma: Correlations with clinical and biological variables. J Clin Pathol 45:416
19. Lipponen P, Eskelinen M (1994) Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erB-2, p53) expression and long-term prognosis. Br J Cancer 69:1120
20. Lipponen PK, Liukkonen TJ (1995) Reduced expression of retinoblastoma (Rb) gene protein is related to cell proliferation and prognosis in transitional cell bladder cancer. J Cancer Res Clin Oncol 121:44
21. Lipponen PK, Nordling S, Eskelinen MJ, Jauhiainen KJ, Terho R, Harju E (1993) Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional cell bladder cancer. Int J Cancer 53:42
22. Lotem J, Sachs L (1993) Regulation by bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentation-competent and -defective myeloid leukemic cells. Cell Growth Differ 3.41
23. Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957
24. Moch H, Sauter G, Mihatsch MJ, Gudat F, Epper R, Waldman FM (1994) p53 but not erbB-2 expression is associated with rapid tumor proliferation in urinary bladder cancer. Hum Pathol 25:1346
25. Mostofi FK, Sobin LH, Torloni H (1973) International histological classification of tumours. In: Mostofi FL, Sobin LH, Torloni H (eds) No. 10 Histological typing of urinary bladder tumours, WHO, Geneva
26. Neal DE, Sharples L, Smith K, Fennelly J, Hall RR, Harris AL (1990) The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 65:1619
27. Ooms ECM, Andersson WAD, Alons CL, Veldhuizen RW, Boon ME (1983) An analysis of the performance of pathologists in grading bladder tumors. Hum Pathol 14:140
28. Pignatelli M, Stamp GW, Kafiri G, Lane D, Bodmer WF (1992) Over-expression of p53 nuclear oncoprotein in colorectal adenomas. Int J Cancer 50:683
29. Piris MA, Pezella F, Martinez-Montero JC, Orradre JL, Villuendas R, Sanchez-Beato M, Cuena R, Cruz MA, Martinez B, Garrido MC, Gatter K, Aiello A, Delia D, Giardini R, Rilke F (1994) p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time. Br J Cancer 69:337
30. Reed JC (1994) Bcl-2 and the resulation of programmed cell death. J Cell Biol 124:1
31. Sachs L, Lotem J (1993) Control of programmed cell death in normal and leucemie cells: new implications for therapy. Blood 82:15
32. Sallinen PK, Haapasalo HK, Visakorpi T, Helen PT, Rantala IS, Isola JJ, Helin HJ (1994) Prognostication of astrocytoma patient survival by Ki-67(MIB-1), PCNA and S-phase fraction using archival paraffin-embedded samples. J Pathol 174:275
33. Sarkis AS, Dalbagni G, Cordon-Cardo C, Zhang ZF, Sheinfeld J, Fair WR, Herr HW, Reuter VE (1993) Nuclear over-expression of p53 protein in transitional cell bladder carcinoma: A marker for disease progression. J Natl Cancer Inst 85:53
34. Sauter G, Haley J, Chew K, Kerschmann R, Moore D, Carroll P, Moch H, Gudat F, Mihatsch MJ, Waldman F (1994) Epidermal growth factor receptor expression is associated with rapid tumor proliferation in bladder cancer. Int J Cancer 57:508
35. Scott N, Sagar P, Stewart J, Blair GE, Dixon MF, Quirke P (1991) p53 in colorectal cancer: Clinicopathological correlation and prognostic significance. Br J Cancer 63:317
36. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B (1995) bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55:237
37. Steinmeyer K, Deppert W (1988) DNA binding properties of murine p53. Oncogene 3:501
38. Szende B, Juhasz E, Lapis K. Schatly AV (1992) Inhibition of two-step urinary bladder carcinogenesis by the somatostatin analogue RC-160. Urol Res 20:383
39. Tsujimoto Y. Croce CM (1986) Analysis of the structure, transcripts and protein products of bcl-2. the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83:5214
40. UICC (1978) International Union Against Cancer. TNM classification of malignant tumours. UICC, Geneva
41. Viale G, Roncalli M, Grimelius L, Graziani D, Wilander E, Johansson H, Bergholm U, Coggi G (1995) Prognostic value of bcl-2 immunoreactivity in medullary thyroid carcinoma. Hum Pathol 26:945
42. Visakorpi T, Kallioniemi OP, Heikkinen A, Koivula T, Isola J (1992) Small subgroup of aggressive, highly proliferative prostatic carcinomas denned by p53 accumulation. J Natl Cancer Inst 84:883
43. Wang Y, Szekely L, Okan I, Klein G, Wiman KG (1993) Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma cell line. Oncogene 8:3427
44. Wright C, Mellon K, Johnston P, Lane DP, Harris AL, Home CHW, Neal DE (1991) Expression of mutant p53. c-erB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer 63:967
45. Wyllie AH (1985) The biology of cell death in tumors. Anticancer Res 5:131
46. Zhu Y-M, Bradbury DA, Russell NH (1994) Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells. Br J Cancer 69:468